US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Astellas Pharma, Inc.

15.09

-0.3400-2.20%

Volume:2.41K

Turnover:36.35K

Market Cap:27.02B

PE:202.95

High:15.31

Open:15.00

Low:15.00

Close:15.43

52wk High:17.35

52wk Low:8.97

Shares:1.79B

Float Shares:1.75B

Volume Ratio:0.84

T/O Rate:0.00%

Dividend:0.51

Dividend Rate:3.40%

EPS(TTM):0.0744

EPS(LYR):0.0628

ROE:19.82%

ROA:7.38%

PB:2.44

PE(LYR):240.13

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Earning Preview: Astellas Pharma, Inc. this quarter’s revenue is expected to increase, and institutional views are mixed with a cautious tilt

Merck, Pfizer, Astellas Drug Combo Gets Speedy FDA Review in Bladder Cancer

Astellas, Pfizer announce FDA grants priority review to PADCEV, Keytruda sBLA

Astellas Pharma: Under Prescription Drug User Fee Act (Pdufa), FDA Has Set Target Action Date of August 17, 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALPMY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":15.09,"timestamp":1777296960000,"preClose":15.43,"halted":0,"volume":2413,"delay":15,"changeRate":-0.02203499675955929,"floatShares":1745183156,"shares":1790310070,"eps":0.074352,"marketStatus":"Trading","change":-0.34,"latestTime":"04-27 09:36:00 EDT Delay","open":15,"high":15.31,"low":15,"amount":36349.653996,"amplitude":0.020091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777320000000},"marketStatusCode":2,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":15.43,"volumeRatio":0.837701},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","floatShares":1745183156,"roa":"7.38%","roe":"19.82%","lyrEps":0.062841,"volumeRatio":0.837701,"shares":1790310070,"dividePrice":0.5124,"high":15.31,"amplitude":0.020091,"preClose":15.43,"low":15,"week52Low":8.97,"pbRate":"2.44","psRate":"2.09","week52High":17.35,"institutionHeld":0,"latestPrice":15.09,"eps":0.074352,"divideRate":0.033956,"volume":2413,"delay":15,"ttmEps":0.074352,"open":15,"prevYearClose":13.29,"prevWeekClose":15.43,"prevMonthClose":16.22,"prevQuarterClose":16.22,"fiveDayClose":16.18,"twentyDayClose":16.09,"sixtyDayClose":13.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMY\",params:#limit:5,,,undefined,":[{"date":"2026-04-27","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777276800000,"name":null,"time":"","dateTimestamp":1777262400000,"actualEps":null},{"market":"US","date":"2025-02-04","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-01","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722499200000,"name":null,"time":"","dateTimestamp":1722484800000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1758254400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1170654788","title":"Earning Preview: Astellas Pharma, Inc. this quarter’s revenue is expected to increase, and institutional views are mixed with a cautious tilt","url":"https://stock-news.laohu8.com/highlight/detail?id=1170654788","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170654788?lang=en_us&edition=fundamental","pubTime":"2026-04-20 10:33","pubTimestamp":1776652404,"startTime":"0","endTime":"0","summary":"Abstract Astellas Pharma, Inc. will report on April 27, 2026 after market close; this preview summarizes last quarter’s performance, current-quarter revenue and earnings projections, segment...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Astellas Pharma, Inc. this quarter’s revenue is expected to increase, and institutional views are mixed with a cautious tilt","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALPMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628476037","title":"Merck, Pfizer, Astellas Drug Combo Gets Speedy FDA Review in Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628476037","media":"Dow Jones","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628476037?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:29","pubTimestamp":1776684540,"startTime":"0","endTime":"0","summary":"Merck, Pfizer and Astellas Pharma have won U.S. Food and Drug Administration priority review for their applications seeking expanded approval of their Keytruda/Padcev drug combination in certain patients with a hard-to-treat form of bladder cancer.The companies on Monday said the applications cover Merck's Keytruda and Keytruda QLEX, each coupled with Padcev from Pfizer and Astellas, for the treatment of patients with muscle-invasive bladder cancer who are eligible for cisplatin-based chemotherapy.The FDA grants priority review to medicines that have the potential to provide significant improvements in the treatment of a serious disease, and the designation shortens the review period. The companies said the FDA has set a target action date of Aug. 17 for the applications.The FDA previously approved the combination of Keytruda and Padcev for adults with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.Merck in 2019 signed a deal to evaluate the combinat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU1917777945.USD","LU1066051225.USD","LU2461242641.AUD","LU2361045086.USD","IE0002270589.USD","LU2357627491.SGD","SG9999014575.USD","LU2468319806.SGD","SG9999015341.SGD","LU1941712348.USD","LU1929549753.HKD","BK4559","SG9999001176.SGD","LU1699723380.USD","SG9999002232.USD","LU1430594728.SGD","LU1941712264.USD","BK4516","LU1934455277.USD","LU0289739699.SGD","LU1023059063.AUD","LU0985481810.HKD","LU1066051811.HKD","LU2106854487.HKD","LU0234572021.USD","LU0006306889.USD","LU1037948541.HKD","LU0942090050.USD","LU0170899867.USD","BK4533","MRK","LU0868494708.USD","LU1066051498.USD","SG9999013999.USD","BK4550","LU0130102774.USD","BK4592","LU2023250843.SGD","LU1116320901.HKD","LU0868494617.USD","LU1585245621.USD","BK4588","LU1934455194.USD","LU2089984988.USD","SG9999014542.SGD","LU0965509283.SGD","IE00BLSP4452.SGD","LU1983299246.USD","IE00B19Z3B42.SGD","LU2360032135.SGD","LU0266013472.USD","LU1974910355.USD","BK4599","LU1201861249.SGD","LU0306807586.USD","PFE","ALPMY","BK4585","LU1989771016.USD","LU0106261372.USD","LU1894683264.USD","LU1894683348.USD","LU0320765646.SGD","LU0130517989.USD","LU0965509101.SGD","IE000M9KFDE8.USD","IE0009355771.USD","LU0208291251.USD","LU0306806265.USD","LU0321505868.SGD","LU0211331839.USD","LU1162221912.USD","LU1883839398.USD","LU0477156953.USD","BK4534","SG9999001176.USD","LU1291159041.SGD","SG9999014567.USD","LU0980610538.SGD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU1989772840.SGD","IE00BBT3K403.USD","LU0861579265.USD","LU0098860793.USD","LU2324357040.USD","LU0648001328.SGD","LU0225771236.USD","LU1989772923.USD","LU1934455863.HKD","SG9999011175.SGD","SG9999014559.SGD","LU0203345920.USD","LU0859254822.USD","LU1035773651.USD","LU0965509010.AUD","LU1037948897.HKD","LU1057294990.SGD","IE00BLSP4239.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU0225284248.USD","LU0203347892.USD","IE00B19Z3581.USD","IE00BN8TJ469.HKD","LU2112291526.USD","IE00B4R5TH58.HKD","LU0965508806.USD","IE0002141913.USD","LU1116320737.USD","LU2125154935.USD","SG9999001440.SGD","LU0122379950.USD","SGXZ57979304.SGD","LU1093756168.USD","LU0070302665.USD","LU0265550946.USD","LU2361044949.HKD","SG9999015358.SGD","IE00BJT1NW94.SGD","LU1069347547.HKD","BK4568","LU1061106388.HKD","LU2023250504.SGD","LU1571399168.USD","LU0265550359.USD","LU0985320562.USD","LU0320765489.SGD","LU2361044865.SGD","SG9999002224.SGD","IE00BSNM7G36.USD","LU0432979614.USD","BK4581","LU0321505439.SGD","LU0456855351.SGD","LU1066053197.SGD","SG9999003800.SGD","LU0238689110.USD","IE00B2B36J28.USD","BK4007","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628742003","title":"Astellas, Pfizer announce FDA grants priority review to PADCEV, Keytruda sBLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742003","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628742003?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:13","pubTimestamp":1776683611,"startTime":"0","endTime":"0","summary":"Astellas Pharma (ALPMY) and Pfizer (PFE) announced that the U.S. Food and Drug Administration accepted for Priority Review a supplemental Biologics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astellas-pfizer-announce-fda-grants-priority-review-to-padcev-keytruda-sbla-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astellas-pfizer-announce-fda-grants-priority-review-to-padcev-keytruda-sbla-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","IE00BLSP4239.USD","LU1093756325.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","BK4550","IE0002141913.USD","LU0859254822.USD","LU1069347547.HKD","LU0006306889.USD","LU1585245621.USD","IE000M9KFDE8.USD","LU0265550946.USD","LU0266013472.USD","LU2468319806.SGD","LU1894683264.USD","BK4516","LU2112291526.USD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU0861579265.USD","LU1934455277.USD","SG9999015341.SGD","SG9999002224.SGD","PFE","SG9999013999.USD","BK4592","LU1057294990.SGD","LU0321505868.SGD","IE00BLSP4452.SGD","BK4568","LU2361044865.SGD","LU2089984988.USD","LU0306806265.USD","IE00BFTCPJ56.SGD","LU1929549753.HKD","LU1883839398.USD","LU0130517989.USD","IE00BJT1NW94.SGD","LU1699723380.USD","LU1116320737.USD","BK4585","LU1061106388.HKD","LU0648001328.SGD","SG9999003800.SGD","LU2324357040.USD","BK4581","LU0211331839.USD","LU2125154935.USD","LU0203347892.USD","LU1116320901.HKD","LU1974910355.USD","LU0477156953.USD","SG9999014575.USD","BK4599","SG9999001440.SGD","LU0203345920.USD","LU1430594728.SGD","LU0868494617.USD","LU0942090050.USD","LU2023250504.SGD","SG9999015358.SGD","LU0130102774.USD","LU1066053197.SGD","LU1941712264.USD","LU0320765646.SGD","LU0225771236.USD","LU1066051811.HKD","LU2361044949.HKD","LU2360032135.SGD","LU0170899867.USD","LU1917777945.USD","LU1571399168.USD","BK4007","SG9999011175.SGD","LU0432979614.USD","LU1066051225.USD","LU0965509010.AUD","LU1894683348.USD","IE00B19Z3581.USD","LU0320765489.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU0238689110.USD","LU0208291251.USD","BK4588","IE00B2B36J28.USD","LU0106261372.USD","LU0225284248.USD","LU0980610538.SGD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0321505439.SGD","SG9999001176.SGD","LU1989772923.USD","IE0009355771.USD","LU1162221912.USD","LU0456855351.SGD","IE0002270589.USD","LU2461242641.AUD","LU2125154778.USD","LU0265550359.USD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU1023059063.AUD","LU1035773651.USD","LU1989772840.SGD","LU1941712348.USD","LU0868494708.USD","LU1934455194.USD","SG9999002232.USD","SG9999014559.SGD","LU0306807586.USD","SG9999014542.SGD","LU1093756168.USD","LU0965509101.SGD","LU2023250843.SGD","LU0985481810.HKD","LU1037948541.HKD","IE00BBT3K403.USD","LU0965508806.USD","LU0289739699.SGD","BK4533","BK4559","LU1983299246.USD","LU2361045086.USD","LU0985320562.USD","IE00BSNM7G36.USD","SG9999014567.USD","LU2106854487.HKD","LU1201861249.SGD","LU0098860793.USD","LU1037948897.HKD","LU0965509283.SGD","LU1989771016.USD","LU2357627491.SGD","ALPMY","SG9999001176.USD","LU0070302665.USD","LU0234572021.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628744145","title":"Astellas Pharma: Under Prescription Drug User Fee Act (Pdufa), FDA Has Set Target Action Date of August 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628744145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628744145?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:45","pubTimestamp":1776681901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nTUA3NYLBJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999002224.SGD","LU0122379950.USD","IE000M9KFDE8.USD","SG9999013999.USD","BK4592","BK4588","BK4007","LU0306806265.USD","LU0058720904.USD","LU1894683264.USD","LU0234572021.USD","BK4568","LU0289739699.SGD","BK4585","LU1066053197.SGD","SG9999001176.USD","LU1023059063.AUD","SG9999001176.SGD","SG9999003800.SGD","BK4534","IE00BLSP4452.SGD","LU0306807586.USD","SG9999002232.USD","ALPMY","IE00BBT3K403.USD","LU0321505868.SGD","LU0985481810.HKD","LU1894683348.USD","LU0170899867.USD","IE00B19Z3581.USD","LU1883839398.USD","BK4599","LU0321505439.SGD","LU0225771236.USD","ALPMF","IE00BLSP4239.USD","BK4581","LU0456855351.SGD","LU1057294990.SGD","SGXZ57979304.SGD","LU0868494617.USD","LU0225284248.USD","BK4533","BK4550","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALPMY\",params:#limit:6,delay:false,,,undefined,":[]}}